{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:00:11Z","timestamp":1794693611743,"version":"4.9.1"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L010305\/1"],"award-info":[{"award-number":["MR\/L010305\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T018712\/1"],"award-info":[{"award-number":["MR\/T018712\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L010305\/1"],"award-info":[{"award-number":["MR\/L010305\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P005748\/1"],"award-info":[{"award-number":["MR\/P005748\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L010305\/1"],"award-info":[{"award-number":["MR\/L010305\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P005748\/1"],"award-info":[{"award-number":["MR\/P005748\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"RCUK | MRC | Medical Research Foundation","doi-asserted-by":"publisher","award":["MR\/P005748\/1"],"award-info":[{"award-number":["MR\/P005748\/1"]}],"id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["U01MH109514"],"award-info":[{"award-number":["U01MH109514"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["U01MH109514"],"award-info":[{"award-number":["U01MH109514"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","id":[{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There has been substantial progress in understanding the genetics of schizophrenia over the past 15 years. This has revealed a highly polygenic condition with the majority of the currently explained heritability coming from common alleles of small effect but with additional contributions from rare copy number and coding variants. Many specific genes and loci have been implicated that provide a firm basis upon which mechanistic research can proceed. These point to disturbances in neuronal, and particularly synaptic, functions that are not confined to a small number of brain regions and circuits. Genetic findings have also revealed the nature of schizophrenia\u2019s close relationship to other conditions, particularly bipolar disorder and childhood neurodevelopmental disorders, and provided an explanation for how common risk alleles persist in the population in the face of reduced fecundity. Current genomic approaches only potentially explain around 40% of heritability, but only a small proportion of this is attributable to robustly identified loci. The extreme polygenicity poses challenges for understanding biological mechanisms. The high degree of pleiotropy points to the need for more transdiagnostic research and the shortcomings of current diagnostic criteria as means of delineating biologically distinct strata. It also poses challenges for inferring causality in observational and experimental studies in both humans and model systems. Finally, the Eurocentric bias of genomic studies needs to be rectified to maximise benefits and ensure these are felt across diverse communities. Further advances are likely to come through the application of new and emerging technologies, such as whole-genome and long-read sequencing, to large and diverse samples. Substantive progress in biological understanding will require parallel advances in functional genomics and proteomics applied to the brain across developmental stages. For these efforts to succeed in identifying disease mechanisms and defining novel strata they will need to be combined with sufficiently granular phenotypic data.<\/jats:p>","DOI":"10.1038\/s41380-023-02293-8","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T06:02:17Z","timestamp":1697608937000},"page":"3638-3647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":197,"title":["Genomic findings in schizophrenia and their implications"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4798-0862","authenticated-orcid":false,"given":"Michael J.","family":"Owen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6617-0289","authenticated-orcid":false,"given":"Sophie E.","family":"Legge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6168-9222","authenticated-orcid":false,"given":"Elliott","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T. R.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7073-2379","authenticated-orcid":false,"given":"Michael C.","family":"O\u2019Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,18]]},"reference":[{"key":"2293_CR1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.schres.2021.10.012","volume":"242","author":"MJ Owen","year":"2022","unstructured":"Owen MJ, Legge SE. The nature of schizophrenia: as broad as it is long. Schizophr Res. 2022;242:109\u201312.","journal-title":"Schizophr Res"},{"key":"2293_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.schres.2013.05.028","volume":"150","author":"R Tandon","year":"2013","unstructured":"Tandon R, Gaebel W, Barch DM, Bustillo J, Gur RE, Heckers S, et al. Definition and description of schizophrenia in the DSM-5. Schizophr Res. 2013;150:3\u201310.","journal-title":"Schizophr Res"},{"key":"2293_CR3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","volume":"388","author":"MJ Owen","year":"2016","unstructured":"Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016;388:86\u201397.","journal-title":"Lancet"},{"key":"2293_CR4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/wps.20624","volume":"18","author":"MF Green","year":"2019","unstructured":"Green MF, Horan WP, Lee J. Nonsocial and social cognition in schizophrenia: current evidence and future directions. World Psychiatry. 2019;18:146\u201361.","journal-title":"World Psychiatry"},{"key":"2293_CR5","doi-asserted-by":"crossref","first-page":"e000057","DOI":"10.1136\/bmjno-2020-000057","volume":"2","author":"L Perju-Dumbrava","year":"2020","unstructured":"Perju-Dumbrava L, Kempster P. Movement disorders in psychiatric patients. BMJ Neurol Open. 2020;2:e000057.","journal-title":"BMJ Neurol Open"},{"key":"2293_CR6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrn4002","volume":"16","author":"DC Javitt","year":"2015","unstructured":"Javitt DC, Sweet RA. Auditory dysfunction in schizophrenia: integrating clinical and basic features. Nat Rev Neurosci. 2015;16:535\u201350.","journal-title":"Nat Rev Neurosci"},{"key":"2293_CR7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","volume":"374","author":"J van Os","year":"2009","unstructured":"van Os J, Kapur S. Schizophrenia. Lancet. 2009;374:635\u201345.","journal-title":"Lancet"},{"key":"2293_CR8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1192\/bjp.186.5.364","volume":"186","author":"N Craddock","year":"2005","unstructured":"Craddock N, Owen MJ. The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry. 2005;186:364\u20136.","journal-title":"Br J Psychiatry"},{"key":"2293_CR9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1192\/bjp.bp.109.073429","volume":"196","author":"N Craddock","year":"2010","unstructured":"Craddock N, Owen MJ. The Kraepelinian dichotomy - going, going\u2026 but still not gone. Br J Psychiatry. 2010;196:92\u20135.","journal-title":"Br J Psychiatry"},{"key":"2293_CR10","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-020-00734-5","volume":"12","author":"E Rees","year":"2020","unstructured":"Rees E, Owen MJ. Translating insights from neuropsychiatric genetics and genomics for precision psychiatry. Genome Med. 2020;12:43.","journal-title":"Genome Med"},{"key":"2293_CR11","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/ng.201","volume":"40","author":"MC O\u2019Donovan","year":"2008","unstructured":"O\u2019Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet. 2008;40:1053\u20135.","journal-title":"Nat Genet"},{"key":"2293_CR12","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","volume":"604","author":"V Trubetskoy","year":"2022","unstructured":"Trubetskoy V, Pardi\u00f1as AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502\u20138.","journal-title":"Nature"},{"key":"2293_CR13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/09540261.2010.515205","volume":"22","author":"KM Abel","year":"2010","unstructured":"Abel KM, Drake R, Goldstein JM. Sex differences in schizophrenia. Int Rev Psychiatry. 2010;22:417\u201328.","journal-title":"Int Rev Psychiatry"},{"key":"2293_CR14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ajhg.2019.07.003","volume":"105","author":"LJ O\u2019Connor","year":"2019","unstructured":"O\u2019Connor LJ, Schoech AP, Hormozdiari F, Gazal S, Patterson N, Price AL. Extreme polygenicity of complex traits is explained by negative selection. Am J Hum Genet. 2019;105:456\u201376.","journal-title":"Am J Hum Genet"},{"key":"2293_CR15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1176\/appi.ajp.21101051","volume":"179","author":"G Hindley","year":"2022","unstructured":"Hindley G, Frei O, Shadrin AA, Cheng W, O\u2019Connell KS, Icick R, et al. Charting the landscape of genetic overlap between mental disorders and related traits beyond genetic correlation. Am J Psychiatry. 2022;179:833\u201343.","journal-title":"Am J Psychiatry"},{"key":"2293_CR16","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1016\/j.cell.2022.10.016","volume":"185","author":"RJ Mangan","year":"2022","unstructured":"Mangan RJ, Alsina FC, Mosti F, Sotelo-Fonseca JE, Snellings DA, Au EH, et al. Adaptive sequence divergence forged new neurodevelopmental enhancers in humans. Cell. 2022;185:4587\u2013603.e4523.","journal-title":"Cell"},{"key":"2293_CR17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng.3725","volume":"49","author":"CR Marshall","year":"2017","unstructured":"Marshall CR, Howrigan DP, Merico D, Thiruvahindrapuram B, Wu W, Greer DS, et al. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet. 2017;49:27\u201335.","journal-title":"Nat Genet"},{"key":"2293_CR18","doi-asserted-by":"crossref","first-page":"6677","DOI":"10.1093\/hmg\/ddu379","volume":"23","author":"L Georgieva","year":"2014","unstructured":"Georgieva L, Rees E, Moran JL, Chambert KD, Milanova V, Craddock N, et al. De novo CNVs in bipolar affective disorder and schizophrenia. Hum Mol Genet. 2014;23:6677\u201383.","journal-title":"Hum Mol Genet"},{"key":"2293_CR19","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archpsyc.56.10.940","volume":"56","author":"KC Murphy","year":"1999","unstructured":"Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry. 1999;56:940\u20135.","journal-title":"Arch Gen Psychiatry"},{"key":"2293_CR20","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamapsychiatry.2016.1831","volume":"73","author":"E Rees","year":"2016","unstructured":"Rees E, Kendall K, Pardinas AF, Legge SE, Pocklington A, Escott-Price V, et al. Analysis of intellectual disability copy number variants for association with schizophrenia. JAMA Psychiatry. 2016;73:963\u20139.","journal-title":"JAMA Psychiatry"},{"key":"2293_CR21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.gde.2021.02.014","volume":"68","author":"E Rees","year":"2021","unstructured":"Rees E, Kirov G. Copy number variation and neuropsychiatric illness. Curr Opin Genet Dev. 2021;68:57\u201363.","journal-title":"Curr Opin Genet Dev"},{"key":"2293_CR22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jamapsychiatry.2021.3392","volume":"79","author":"X Calle Sanchez","year":"2022","unstructured":"Calle Sanchez X, Helenius D, Bybjerg-Grauholm J, Pedersen C, Hougaard DM, Borglum AD, et al. Comparing copy number variations in a danish case cohort of individuals with psychiatric disorders. JAMA Psychiatry. 2022;79:59\u201369.","journal-title":"JAMA Psychiatry"},{"key":"2293_CR23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/mp.2013.156","volume":"19","author":"E Rees","year":"2014","unstructured":"Rees E, Kirov G, Sanders A, Walters JT, Chambert KD, Shi J, et al. Evidence that duplications of 22q11.2 protect against schizophrenia. Mol Psychiatry. 2014;19:37\u201340.","journal-title":"Mol Psychiatry"},{"key":"2293_CR24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.biopsych.2015.11.012","volume":"80","author":"Z Li","year":"2016","unstructured":"Li Z, Chen J, Xu Y, Yi Q, Ji W, Wang P, et al. Genome-wide analysis of the role of copy number variation in schizophrenia risk in Chinese. Biol Psychiatry. 2016;80:331\u20137.","journal-title":"Biol Psychiatry"},{"key":"2293_CR25","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.cell.2012.02.039","volume":"148","author":"D Malhotra","year":"2012","unstructured":"Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012;148:1223\u201341.","journal-title":"Cell"},{"key":"2293_CR26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41593-019-0564-3","volume":"23","author":"DP Howrigan","year":"2020","unstructured":"Howrigan DP, Rose SA, Samocha KE, Fromer M, Cerrato F, Chen WJ, et al. Exome sequencing in schizophrenia-affected parent-offspring trios reveals risk conferred by protein-coding de novo mutations. Nat Neurosci. 2020;23:185\u201393.","journal-title":"Nat Neurosci"},{"key":"2293_CR27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature12929","volume":"506","author":"M Fromer","year":"2014","unstructured":"Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, et al. De novo mutations in schizophrenia implicate synaptic networks. Nature. 2014;506:179\u201384.","journal-title":"Nature"},{"key":"2293_CR28","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/nn.4402","volume":"19","author":"G Genovese","year":"2016","unstructured":"Genovese G, Fromer M, Stahl EA, Ruderfer DM, Chambert K, Landen M, et al. Increased burden of ultra-rare protein-altering variants among 4877 individuals with schizophrenia. Nat Neurosci. 2016;19:1433\u201341.","journal-title":"Nat Neurosci"},{"key":"2293_CR29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-022-04556-w","volume":"604","author":"T Singh","year":"2022","unstructured":"Singh T, Poterba T, Curtis D, Akil H, Al Eissa M, Barchas JD, et al. Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature. 2022;604:509\u201316.","journal-title":"Nature"},{"key":"2293_CR30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41588-023-01305-1","volume":"55","author":"D Liu","year":"2023","unstructured":"Liu D, Meyer D, Fennessy B, Feng C, Cheng E, Johnson JS, et al. Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations. Nat Genet. 2023;55:369\u201376.","journal-title":"Nat Genet"},{"key":"2293_CR31","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archpsyc.60.12.1187","volume":"60","author":"PF Sullivan","year":"2003","unstructured":"Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60:1187\u201392.","journal-title":"Arch Gen Psychiatry"},{"key":"2293_CR32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(09)60072-6","volume":"373","author":"P Lichtenstein","year":"2009","unstructured":"Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009;373:234\u20139.","journal-title":"Lancet"},{"key":"2293_CR33","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41586-022-05684-z","volume":"614","author":"DJ Weiner","year":"2023","unstructured":"Weiner DJ, Nadig A, Jagadeesh KA, Dey KK, Neale BM, Robinson EB, et al. Polygenic architecture of rare coding variation across 394,783 exomes. Nature. 2023;614:492\u20139.","journal-title":"Nature"},{"key":"2293_CR34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature12975","volume":"506","author":"SM Purcell","year":"2014","unstructured":"Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature. 2014;506:185\u201390.","journal-title":"Nature"},{"key":"2293_CR35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41588-021-00997-7","volume":"54","author":"P Wainschtein","year":"2022","unstructured":"Wainschtein P, Jain D, Zheng Z, Group TOAW, Consortium NT-OfPM, Cupples LA. et al. Assessing the contribution of rare variants to complex trait heritability from whole-genome sequence data. Nat Genet. 2022;54:263\u201373.","journal-title":"Nat Genet"},{"key":"2293_CR36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203\u20139.","journal-title":"Nature"},{"key":"2293_CR37","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/s41562-022-01408-5","volume":"6","author":"SK Jang","year":"2022","unstructured":"Jang SK, Evans L, Fialkowski A, Arnett DK, Ashley-Koch AE, Barnes KC, et al. Rare genetic variants explain missing heritability in smoking. Nat Hum Behav. 2022;6:1577\u201386.","journal-title":"Nat Hum Behav"},{"key":"2293_CR38","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s41588-019-0512-x","volume":"51","author":"M Lam","year":"2019","unstructured":"Lam M, Chen CY, Li Z, Martin AR, Bryois J, Ma X, et al. Comparative genetic architectures of schizophrenia in East Asian and European populations. Nat Genet. 2019;51:1670\u20138.","journal-title":"Nat Genet"},{"key":"2293_CR39","doi-asserted-by":"crossref","first-page":"100212","DOI":"10.1016\/j.xgen.2022.100212","volume":"2","author":"K Tsuo","year":"2022","unstructured":"Tsuo K, Zhou W, Wang Y, Kanai M, Namba S, Gupta R, et al. Multi-ancestry meta-analysis of asthma identifies novel associations and highlights the value of increased power and diversity. Cell Genom. 2022;2:100212.","journal-title":"Cell Genom"},{"key":"2293_CR40","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019;51:584\u201391.","journal-title":"Nat Genet"},{"key":"2293_CR41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/schbul\/sbaa133","volume":"47","author":"TB Bigdeli","year":"2021","unstructured":"Bigdeli TB, Fanous AH, Li Y, Rajeevan N, Sayward F, Genovese G, et al. Genome-wide association studies of schizophrenia and bipolar disorder in a diverse cohort of US veterans. Schizophr Bull. 2021;47:517\u201329.","journal-title":"Schizophr Bull"},{"key":"2293_CR42","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/ng.2711","volume":"45","author":"SH Lee","year":"2013","unstructured":"Cross-Disorder Group of the Psychiatric Genomics Consortium, Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45:984\u201394.","journal-title":"Nat Genet"},{"key":"2293_CR43","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/nm.4196","volume":"22","author":"MC O\u2019Donovan","year":"2016","unstructured":"O\u2019Donovan MC, Owen MJ. The implications of the shared genetics of psychiatric disorders. Nat Med. 2016;22:1214\u20139.","journal-title":"Nat Med"},{"key":"2293_CR44","doi-asserted-by":"crossref","first-page":"eaap8757","DOI":"10.1126\/science.aap8757","volume":"360","author":"V Anttila","year":"2018","unstructured":"Brainstorm Consortium, Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK, Bras J, et al. Analysis of shared heritability in common disorders of the brain. Science. 2018;360:eaap8757.","journal-title":"Science"},{"key":"2293_CR45","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.abo2059","volume":"378","author":"R Border","year":"2022","unstructured":"Border R, Athanasiadis G, Buil A, Schork AJ, Cai N, Young AI, et al. Cross-trait assortative mating is widespread and inflates genetic correlation estimates. Science. 2022;378:754\u201361.","journal-title":"Science"},{"key":"2293_CR46","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.3406","volume":"47","author":"B Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan B, Finucane HK, Anttila V, Gusev A, Day FR, Loh PR, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015;47:1236\u201341.","journal-title":"Nat Genet"},{"key":"2293_CR47","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jamapsychiatry.2022.2742","volume":"79","author":"TB Bigdeli","year":"2022","unstructured":"Bigdeli TB, Voloudakis G, Barr PB, Gorman BR, Genovese G, Peterson RE, et al. Penetrance and pleiotropy of polygenic risk scores for schizophrenia, bipolar disorder, and depression among adults in the US veterans affairs health care system. JAMA Psychiatry. 2022;79:1092\u2013101.","journal-title":"JAMA Psychiatry"},{"key":"2293_CR48","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1176\/appi.ajp.2019.18091085","volume":"176","author":"AB Zheutlin","year":"2019","unstructured":"Zheutlin AB, Dennis J, Karlsson Linner R, Moscati A, Restrepo N, Straub P, et al. Penetrance and pleiotropy of polygenic risk scores for schizophrenia in 106,160 patients across four health care systems. Am J Psychiatry. 2019;176:846\u201355.","journal-title":"Am J Psychiatry"},{"key":"2293_CR49","doi-asserted-by":"crossref","first-page":"e1008185","DOI":"10.1371\/journal.pgen.1008185","volume":"16","author":"B Leppert","year":"2020","unstructured":"Leppert B, Millard LAC, Riglin L, Davey Smith G, Thapar A, Tilling K, et al. A cross-disorder PRS-pheWAS of 5 major psychiatric disorders in UK Biobank. PLoS Genet. 2020;16:e1008185.","journal-title":"PLoS Genet"},{"key":"2293_CR50","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/jamapsychiatry.2017.3485","volume":"75","author":"J Allardyce","year":"2018","unstructured":"Allardyce J, Leonenko G, Hamshere M, Pardinas AF, Forty L, Knott S, et al. Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder. JAMA Psychiatry. 2018;75:28\u201335.","journal-title":"JAMA Psychiatry"},{"key":"2293_CR51","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/wps.20440","volume":"16","author":"MJ Owen","year":"2017","unstructured":"Owen MJ, O\u2019Donovan MC. Schizophrenia and the neurodevelopmental continuum:evidence from genomics. World Psychiatry. 2017;16:227\u201335.","journal-title":"World Psychiatry"},{"key":"2293_CR52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41593-019-0565-2","volume":"23","author":"E Rees","year":"2020","unstructured":"Rees E, Han J, Morgan J, Carrera N, Escott-Price V, Pocklington AJ, et al. De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia. Nat Neurosci. 2020;23:179\u201384.","journal-title":"Nat Neurosci"},{"key":"2293_CR53","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25532-4","volume":"12","author":"E Rees","year":"2021","unstructured":"Rees E, Creeth HDJ, Hwu HG, Chen WJ, Tsuang M, Glatt SJ, et al. Schizophrenia, autism spectrum disorders and developmental disorders share specific disruptive coding mutations. Nat Commun. 2021;12:5353.","journal-title":"Nat Commun"},{"key":"2293_CR54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajmg.b.31145","volume":"156B","author":"FV Rijsdijk","year":"2011","unstructured":"Rijsdijk FV, Gottesman II, McGuffin P, Cardno AG. Heritability estimates for psychotic symptom dimensions in twins with psychotic disorders. Am J Med Genet B Neuropsychiatr Genet. 2011;156B:89\u201398.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"2293_CR55","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jamapsychiatry.2021.1961","volume":"78","author":"SE Legge","year":"2021","unstructured":"Legge SE, Cardno AG, Allardyce J, Dennison C, Hubbard L, Pardinas AF, et al. Associations between schizophrenia polygenic liability, symptom dimensions, and cognitive ability in schizophrenia. JAMA Psychiatry. 2021;78:1143\u201351.","journal-title":"JAMA Psychiatry"},{"key":"2293_CR56","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/mp.2013.138","volume":"19","author":"DM Ruderfer","year":"2014","unstructured":"Ruderfer DM, Fanous AH, Ripke S, McQuillin A, Amdur RL. Schizophrenia Working Group of the Psychiatric Genomics C et al. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol Psychiatry. 2014;19:1017\u201324.","journal-title":"Mol Psychiatry"},{"key":"2293_CR57","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1176\/appi.ajp.2012.12020218","volume":"169","author":"AH Fanous","year":"2012","unstructured":"Fanous AH, Zhou B, Aggen SH, Bergen SE, Amdur RL, Duan J, et al. Genome-wide association study of clinical dimensions of schizophrenia: polygenic effect on disorganized symptoms. Am J Psychiatry. 2012;169:1309\u201317.","journal-title":"Am J Psychiatry"},{"key":"2293_CR58","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41380-022-01850-x","volume":"28","author":"J Taylor","year":"2023","unstructured":"Taylor J, de Vries YA, van Loo HM, Kendler KS. Clinical characteristics indexing genetic differences in schizophrenia: a systematic review. Mol Psychiatry. 2023;28:883\u201390.","journal-title":"Mol Psychiatry"},{"key":"2293_CR59","first-page":"1","volume":"223","author":"M Ahangari","year":"2022","unstructured":"Ahangari M, Bustamante D, Kirkpatrick R, Nguyen TH, Verrelli BC, Fanous A, et al. Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia. Br J Psychiatry. 2022;223:1\u20138.","journal-title":"Br J Psychiatry"},{"key":"2293_CR60","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-019-0612-5","volume":"9","author":"KG Jonas","year":"2019","unstructured":"Jonas KG, Lencz T, Li K, Malhotra AK, Perlman G, Fochtmann LJ, et al. Schizophrenia polygenic risk score and 20-year course of illness in psychotic disorders. Transl Psychiatry. 2019;9:300.","journal-title":"Transl Psychiatry"},{"key":"2293_CR61","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1192\/bjp.bp.110.087866","volume":"198","author":"ML Hamshere","year":"2011","unstructured":"Hamshere ML, O\u2019Donovan MC, Jones IR, Jones L, Kirov G, Green EK, et al. Polygenic dissection of the bipolar phenotype. Br J Psychiatry. 2011;198:284\u20138.","journal-title":"Br J Psychiatry"},{"key":"2293_CR62","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-00996-y","volume":"10","author":"BJ Coombes","year":"2020","unstructured":"Coombes BJ, Markota M, Mann JJ, Colby C, Stahl E, Talati A, et al. Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores. Transl Psychiatry. 2020;10:314.","journal-title":"Transl Psychiatry"},{"key":"2293_CR63","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01526-0","volume":"11","author":"D Quattrone","year":"2021","unstructured":"Quattrone D, Reininghaus U, Richards AL, Tripoli G, Ferraro L, Quattrone A, et al. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study. Transl Psychiatry. 2021;11:423.","journal-title":"Transl Psychiatry"},{"key":"2293_CR64","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.cell.2018.05.046","volume":"173","author":"Bipolar Disorder Working Group of the Psychiatric Genomics Consortium.","year":"2018","unstructured":"Bipolar Disorder Working Group of the Psychiatric Genomics Consortium. Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes. Cell. 2018;173:1705\u201315.e1716.","journal-title":"Cell"},{"key":"2293_CR65","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/schbul\/sbab036","volume":"47","author":"CA Dennison","year":"2021","unstructured":"Dennison CA, Legge SE, Hubbard L, Lynham AJ, Zammit S, Holmans P, et al. Risk factors, clinical features, and polygenic risk scores in schizophrenia and schizoaffective disorder depressive-type. Schizophr Bull. 2021;47:1375\u201384.","journal-title":"Schizophr Bull"},{"key":"2293_CR66","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41562-019-0566-x","volume":"3","author":"AD Grotzinger","year":"2019","unstructured":"Grotzinger AD, Rhemtulla M, de Vlaming R, Ritchie SJ, Mallard TT, Hill WD, et al. Genomic structural equation modelling provides insights into the multivariate genetic architecture of complex traits. Nat Hum Behav. 2019;3:513\u201325.","journal-title":"Nat Hum Behav"},{"key":"2293_CR67","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/jamapsychiatry.2022.2594","volume":"79","author":"AL Richards","year":"2022","unstructured":"Richards AL, Cardno A, Harold G, Craddock NJ, Di Florio A, Jones L, et al. Genetic liabilities differentiating bipolar disorder, schizophrenia, and major depressive disorder, and phenotypic heterogeneity in bipolar disorder. JAMA Psychiatry. 2022;79:1032\u20139.","journal-title":"JAMA Psychiatry"},{"key":"2293_CR68","doi-asserted-by":"publisher","unstructured":"McCutcheon RA, Keefe RSE, McGuire PK Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol Psychiatry. 2023. https:\/\/doi.org\/10.1038\/s41380-023-01949-9. Online ahead of print.","DOI":"10.1038\/s41380-023-01949-9"},{"key":"2293_CR69","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41588-018-0152-6","volume":"50","author":"JE Savage","year":"2018","unstructured":"Savage JE, Jansen PR, Stringer S, Watanabe K, Bryois J, de Leeuw CA, et al. Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nat Genet. 2018;50:912\u20139.","journal-title":"Nat Genet"},{"key":"2293_CR70","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/schbul\/sbv168","volume":"42","author":"L Hubbard","year":"2016","unstructured":"Hubbard L, Tansey KE, Rai D, Jones P, Ripke S, Chambert KD, et al. Evidence of common genetic overlap between schizophrenia and cognition. Schizophr Bull. 2016;42:832\u201342.","journal-title":"Schizophr Bull"},{"key":"2293_CR71","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/mp.2013.166","volume":"19","author":"T Lencz","year":"2014","unstructured":"Lencz T, Knowles E, Davies G, Guha S, Liewald DC, Starr JM, et al. Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the cognitive genomics consortium (COGENT). Mol Psychiatry. 2014;19:168\u201374.","journal-title":"Mol Psychiatry"},{"key":"2293_CR72","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/gbb.12401","volume":"17","author":"SH Wang","year":"2018","unstructured":"Wang SH, Hsiao PC, Yeh LL, Liu CM, Liu CC, Hwang TJ, et al. Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia. Genes Brain Behav. 2018;17:49\u201355.","journal-title":"Genes Brain Behav"},{"key":"2293_CR73","first-page":"336","volume":"46","author":"AL Richards","year":"2020","unstructured":"Richards AL, Pardinas AF, Frizzati A, Tansey KE, Lynham AJ, Holmans P, et al. The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia. Schizophr Bull. 2020;46:336\u201344.","journal-title":"Schizophr Bull"},{"key":"2293_CR74","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/jcm9020341","volume":"9","author":"J Mallet","year":"2020","unstructured":"Mallet J, Le Strat Y, Dubertret C, Gorwood P. Polygenic risk scores shed light on the relationship between schizophrenia and cognitive functioning: review and meta-analysis. J Clin Med. 2020;9:341.","journal-title":"J Clin Med"},{"key":"2293_CR75","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-018-0124-8","volume":"8","author":"R Shafee","year":"2018","unstructured":"Shafee R, Nanda P, Padmanabhan JL, Tandon N, Alliey-Rodriguez N, Kalapurakkel S, et al. Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Transl Psychiatry. 2018;8:78.","journal-title":"Transl Psychiatry"},{"key":"2293_CR76","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature12818","volume":"505","author":"H Stefansson","year":"2014","unstructured":"Stefansson H, Meyer-Lindenberg A, Steinberg S, Magnusdottir B, Morgen K, Arnarsdottir S, et al. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature. 2014;505:361\u20136.","journal-title":"Nature"},{"key":"2293_CR77","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1192\/bjp.2018.301","volume":"214","author":"KM Kendall","year":"2019","unstructured":"Kendall KM, Bracher-Smith M, Fitzpatrick H, Lynham A, Rees E, Escott-Price V, et al. Cognitive performance and functional outcomes of carriers of pathogenic copy number variants: analysis of the UK Biobank. Br J Psychiatry. 2019;214:297\u2013304.","journal-title":"Br J Psychiatry"},{"key":"2293_CR78","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.biopsych.2020.11.025","volume":"90","author":"L Hubbard","year":"2021","unstructured":"Hubbard L, Rees E, Morris DW, Lynham AJ, Richards AL, Pardinas AF, et al. Rare copy number variants are associated with poorer cognition in schizophrenia. Biol Psychiatry. 2021;90:28\u201334.","journal-title":"Biol Psychiatry"},{"key":"2293_CR79","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamapsychiatry.2022.2289","volume":"79","author":"HDJ Creeth","year":"2022","unstructured":"Creeth HDJ, Rees E, Legge SE, Dennison CA, Holmans P, Walters JTR, et al. Ultrarare coding variants and cognitive function in schizophrenia. JAMA Psychiatry. 2022;79:963\u201370.","journal-title":"JAMA Psychiatry"},{"key":"2293_CR80","doi-asserted-by":"publisher","unstructured":"Rammos A, Kirov G, Hubbard L, Walters JTR, Holmans P, Owen MJ et al. Family-based analysis of the contribution of rare and common genetic variants to school performance in schizophrenia. Mol Psychiatry. 2023. https:\/\/doi.org\/10.1038\/s41380-023-02013-2. Online ahead of print.","DOI":"10.1038\/s41380-023-02013-2"},{"key":"2293_CR81","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1038\/s41380-022-01500-2","volume":"27","author":"J Song","year":"2022","unstructured":"Song J, Yao S, Kowalec K, Lu Y, Sariaslan A, Szatkiewicz JP, et al. The impact of educational attainment, intelligence and intellectual disability on schizophrenia: a Swedish population-based register and genetic study. Mol Psychiatry. 2022;27:2439\u201347.","journal-title":"Mol Psychiatry"},{"key":"2293_CR82","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2020.05.020","volume":"223","author":"TD Habtewold","year":"2020","unstructured":"Habtewold TD, Liemburg EJ, Islam MA, de Zwarte SMC, Boezen HM, Investigators G, et al. Association of schizophrenia polygenic risk score with data-driven cognitive subtypes: A six-year longitudinal study in patients, siblings and controls. Schizophr Res. 2020;223:135\u201347.","journal-title":"Schizophr Res"},{"key":"2293_CR83","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-01114-8","volume":"10","author":"AP Kepinska","year":"2020","unstructured":"Kepinska AP, MacCabe JH, Cadar D, Steptoe A, Murray RM, Ajnakina O. Schizophrenia polygenic risk predicts general cognitive deficit but not cognitive decline in healthy older adults. Transl Psychiatry. 2020;10:422.","journal-title":"Transl Psychiatry"},{"key":"2293_CR84","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/mp.2015.130","volume":"21","author":"SM Meier","year":"2016","unstructured":"Meier SM, Agerbo E, Maier R, Pedersen CB, Lang M, Grove J, et al. High loading of polygenic risk in cases with chronic schizophrenia. Mol Psychiatry. 2016;21:969\u201374.","journal-title":"Mol Psychiatry"},{"key":"2293_CR85","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/mp.2014.56","volume":"20","author":"J Frank","year":"2015","unstructured":"Frank J, Lang M, Witt SH, Strohmaier J, Rujescu D, Cichon S, et al. Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients. Mol Psychiatry. 2015;20:150\u20131.","journal-title":"Mol Psychiatry"},{"key":"2293_CR86","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/schbul\/sbx007","volume":"43","author":"T Wimberley","year":"2017","unstructured":"Wimberley T, Gasse C, Meier SM, Agerbo E, MacCabe JH, Horsdal HT. Polygenic risk score for schizophrenia and treatment-resistant Schizophrenia. Schizophr Bull. 2017;43:1064\u20139.","journal-title":"Schizophr Bull"},{"key":"2293_CR87","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/S0033291715001701","volume":"46","author":"AK Martin","year":"2016","unstructured":"Martin AK, Mowry B. Increased rare duplication burden genomewide in patients with treatment-resistant schizophrenia. Psychol Med. 2016;46:469\u201376.","journal-title":"Psychol Med"},{"key":"2293_CR88","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1192\/bjp.2019.120","volume":"216","author":"SE Legge","year":"2020","unstructured":"Legge SE, Dennison CA, Pardinas AF, Rees E, Lynham AJ, Hopkins L, et al. Clinical indicators of treatment-resistant psychosis. Br J Psychiatry. 2020;216:259\u201366.","journal-title":"Br J Psychiatry"},{"key":"2293_CR89","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1038\/s41380-019-0575-1","volume":"26","author":"K Kowalec","year":"2021","unstructured":"Kowalec K, Lu Y, Sariaslan A, Song J, Ploner A, Dalman C, et al. Increased schizophrenia family history burden and reduced premorbid IQ in treatment-resistant schizophrenia: a Swedish National Register and Genomic Study. Mol Psychiatry. 2021;26:4487\u201395.","journal-title":"Mol Psychiatry"},{"key":"2293_CR90","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jamapsychiatry.2021.3799","volume":"79","author":"AF Pardinas","year":"2022","unstructured":"Pardinas AF, Smart SE, Willcocks IR, Holmans PA, Dennison CA, Lynham AJ, et al. Interaction testing and polygenic risk scoring to estimate the association of common genetic variants with treatment resistance in schizophrenia. JAMA Psychiatry. 2022;79:260\u20139.","journal-title":"JAMA Psychiatry"},{"key":"2293_CR91","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/schbul\/sbac175","volume":"49","author":"M Farrell","year":"2022","unstructured":"Farrell M, Dietterich TE, Harner MK, Bruno LM, Filmyer DM, Shaughnessy RA, et al. Increased prevalence of rare copy number variants in treatment-resistant psychosis. Schizophr Bull. 2022;49:881\u201392.","journal-title":"Schizophr Bull"},{"key":"2293_CR92","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S2215-0366(15)00553-2","volume":"3","author":"DM Ruderfer","year":"2016","unstructured":"Ruderfer DM, Charney AW, Readhead B, Kidd BA, Kahler AK, Kenny PJ, et al. Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach. Lancet Psychiatry. 2016;3:350\u20137.","journal-title":"Lancet Psychiatry"},{"key":"2293_CR93","doi-asserted-by":"crossref","first-page":"e2112560118","DOI":"10.1073\/pnas.2112560118","volume":"118","author":"AW Zoghbi","year":"2021","unstructured":"Zoghbi AW, Dhindsa RS, Goldberg TE, Mehralizade A, Motelow JE, Wang X, et al. High-impact rare genetic variants in severe schizophrenia. Proc Natl Acad Sci USA. 2021;118:e2112560118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2293_CR94","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/jamapsychiatry.2013.268","volume":"70","author":"RA Power","year":"2013","unstructured":"Power RA, Kyaga S, Uher R, MacCabe JH, Langstrom N, Landen M, et al. Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings. JAMA Psychiatry. 2013;70:22\u201330.","journal-title":"JAMA Psychiatry"},{"key":"2293_CR95","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1017\/S0140525X06009095","volume":"29","author":"MC Keller","year":"2006","unstructured":"Keller MC, Miller G. Resolving the paradox of common, harmful, heritable mental disorders: which evolutionary genetic models work best? Behav Brain Sci. 2006;29:385\u2013404.","journal-title":"Behav Brain Sci"},{"key":"2293_CR96","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-clinpsy-050817-084854","volume":"14","author":"MC Keller","year":"2018","unstructured":"Keller MC. Evolutionary perspectives on genetic and environmental risk factors for psychiatric disorders. Annu Rev Clin Psychol. 2018;14:471\u201393.","journal-title":"Annu Rev Clin Psychol"},{"key":"2293_CR97","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.biopsych.2011.07.011","volume":"70","author":"E Rees","year":"2011","unstructured":"Rees E, Moskvina V, Owen MJ, O\u2019Donovan MC, Kirov G. De novo rates and selection of schizophrenia-associated copy number variants. Biol Psychiatry. 2011;70:1109\u201314.","journal-title":"Biol Psychiatry"},{"key":"2293_CR98","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41588-018-0059-2","volume":"50","author":"AF Pardinas","year":"2018","unstructured":"Pardinas AF, Holmans P, Pocklington AJ, Escott-Price V, Ripke S, Carrera N, et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat Genet. 2018;50:381\u20139.","journal-title":"Nat Genet"},{"key":"2293_CR99","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1176\/appi.ajp.2018.18020140","volume":"176","author":"V Escott-Price","year":"2019","unstructured":"Escott-Price V, Pardinas AF, Santiago E, Walters J, Kirov G, Owen MJ, et al. The relationship between common variant schizophrenia liability and number of offspring in the UK Biobank. Am J Psychiatry. 2019;176:661\u20136.","journal-title":"Am J Psychiatry"},{"key":"2293_CR100","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/ng.3954","volume":"49","author":"S Gazal","year":"2017","unstructured":"Gazal S, Finucane HK, Furlotte NA, Loh PR, Palamara PF, Liu X, et al. Linkage disequilibrium-dependent architecture of human complex traits shows action of negative selection. Nat Genet. 2017;49:1421\u20137.","journal-title":"Nat Genet"},{"key":"2293_CR101","first-page":"178","volume":"42","author":"M Li","year":"2016","unstructured":"Li M, Wu DD, Yao YG, Huo YX, Liu JW, Su B, et al. Recent positive selection drives the expansion of a schizophrenia risk nonsynonymous variant at SLC39A8 in Europeans. Schizophr Bull. 2016;42:178\u201390.","journal-title":"Schizophr Bull"},{"key":"2293_CR102","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.biopsych.2020.01.017","volume":"89","author":"MJ Owen","year":"2021","unstructured":"Owen MJ, O\u2019Donovan MC. Large-scale genomics: a paradigm shift in psychiatry? Biol Psychiatry. 2021;89:5\u20137.","journal-title":"Biol Psychiatry"},{"key":"2293_CR103","unstructured":"Weinberger DR. The pathogenesis of schizophrenia: A neurodevelopmental\u00a0theory. In Nasrallah HA, Weinberger DR (eds) The Neurology of\u00a0Schizophrenia. Amsterdam: Elsevier Science Publishers; 1986, pp 397\u2013406."},{"key":"2293_CR104","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/bmj.295.6600.681","volume":"295","author":"RM Murray","year":"1987","unstructured":"Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed). 1987;295:681\u20132.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2293_CR105","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41588-019-0344-8","volume":"51","author":"J Grove","year":"2019","unstructured":"Grove J, Ripke S, Als TD, Mattheisen M, Walters RK, Won H, et al. Identification of common genetic risk variants for autism spectrum disorder. Nat Genet. 2019;51:431\u201344.","journal-title":"Nat Genet"},{"key":"2293_CR106","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41588-022-01285-8","volume":"55","author":"D Demontis","year":"2023","unstructured":"Demontis D, Walters GB, Athanasiadis G, Walters R, Therrien K, Nielsen TT, et al. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nat Genet. 2023;55:198\u2013208.","journal-title":"Nat Genet"},{"key":"2293_CR107","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41593-019-0527-8","volume":"22","author":"FK Satterstrom","year":"2019","unstructured":"Satterstrom FK, Walters RK, Singh T, Wigdor EM, Lescai F, Demontis D, et al. Autism spectrum disorder and attention deficit hyperactivity disorder have a similar burden of rare protein-truncating variants. Nat Neurosci. 2019;22:1961\u20135.","journal-title":"Nat Neurosci"},{"key":"2293_CR108","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/mp.2015.170","volume":"21","author":"KE Tansey","year":"2016","unstructured":"Tansey KE, Rees E, Linden DE, Ripke S, Chambert KD, Moran JL, et al. Common alleles contribute to schizophrenia in CNV carriers. Mol Psychiatry. 2016;21:1153.","journal-title":"Mol Psychiatry"},{"key":"2293_CR109","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1038\/s41380-020-0654-3","volume":"26","author":"I Cleynen","year":"2021","unstructured":"Cleynen I, Engchuan W, Hestand MS, Heung T, Holleman AM, Johnston HR, et al. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion. Mol Psychiatry. 2021;26:4496\u2013510.","journal-title":"Mol Psychiatry"},{"key":"2293_CR110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1176\/appi.ajp.2018.17040467","volume":"176","author":"SE Bergen","year":"2019","unstructured":"Bergen SE, Ploner A, Howrigan D, Group CNVA, the Schizophrenia Working Group of the Psychiatric Genomics C, O\u2019Donovan MC, et al. Joint contributions of rare copy number variants and common SNPs to risk for schizophrenia. Am J Psychiatry. 2019;176:29\u201335.","journal-title":"Am J Psychiatry"},{"key":"2293_CR111","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41588-022-01072-5","volume":"54","author":"V Warrier","year":"2022","unstructured":"Warrier V, Zhang X, Reed P, Havdahl A, Moore TM, Cliquet F, et al. Genetic correlates of phenotypic heterogeneity in autism. Nat Genet. 2022;54:1293\u2013304.","journal-title":"Nat Genet"},{"key":"2293_CR112","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(13)62036-X","volume":"383","author":"OD Howes","year":"2014","unstructured":"Howes OD, Murray RM. Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet. 2014;383:1677\u201387.","journal-title":"Lancet"},{"key":"2293_CR113","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics Consortium.","year":"2014","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421\u20137.","journal-title":"Nature"},{"key":"2293_CR114","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biopsych.2014.07.011","volume":"77","author":"J Hall","year":"2015","unstructured":"Hall J, Trent S, Thomas KL, O\u2019Donovan MC, Owen MJ. Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity. Biol Psychiatry. 2015;77:52\u201358.","journal-title":"Biol Psychiatry"},{"key":"2293_CR115","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/mp.2011.154","volume":"17","author":"G Kirov","year":"2012","unstructured":"Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D, et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry. 2012;17:142\u201353.","journal-title":"Mol Psychiatry"},{"key":"2293_CR116","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.neuron.2015.04.022","volume":"86","author":"AJ Pocklington","year":"2015","unstructured":"Pocklington AJ, Rees E, Walters JT, Han J, Kavanagh DH, Chambert KD, et al. Novel findings from CNVs implicate inhibitory and excitatory signaling complexes in schizophrenia. Neuron. 2015;86:1203\u201314.","journal-title":"Neuron"},{"key":"2293_CR117","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/mp.2015.63","volume":"21","author":"TG van Erp","year":"2016","unstructured":"van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016;21:547\u201353.","journal-title":"Mol Psychiatry"},{"key":"2293_CR118","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/schbul\/sbab125","volume":"48","author":"TM Lancaster","year":"2022","unstructured":"Lancaster TM, Dimitriadis SI, Perry G, Zammit S, O\u2019Donovan MC, Linden DE. Morphometric analysis of structural MRI using schizophrenia meta-analytic priors distinguish patients from controls in two independent samples and in a sample of individuals with high polygenic risk. Schizophr Bull. 2022;48:524\u201332.","journal-title":"Schizophr Bull"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02293-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02293-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02293-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T05:21:43Z","timestamp":1702963303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02293-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":118,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2293"],"URL":"https:\/\/doi.org\/10.1038\/s41380-023-02293-8","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"28 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ER, JTRW, MCO and MJO reported receiving grants from Akrivia Health outside the submitted work. JTRW, MJO and MCO reported receiving grants from Takeda Pharmaceutical Company Ltd outside the submitted work. Takeda and Akrivia played no part in the conception, design, implementation, or interpretation of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}